TABLE 1.
Patient characteristics
| Total population N=62 | LGE - N=31 | LGE+N=31 | P-value | |
|---|---|---|---|---|
| Age | 57.2±10.9 | 58.4±10.3 | 58.8±11.3 | .89 |
| Female | 43 (69%) | 22 (71%) | 21 (68%) | .78 |
| Hypertension | 27 (44%) | 11 (35%) | 16 (52%) | .21 |
| Diabetes mellitus | 12 (19%) | 4 (13%) | 9 (29%) | .07 |
| Dyslipidemia | 17 (27%) | 7 (23%) | 10 (32%) | .4 |
| Coronary artery disease | 9 (15%) | 4 (13%) | 5 (16%) | .72 |
| Smoking | 4 (7%) | 0 (0%) | 4 (13%) | .04* |
| Atrial fibrillation | 13 (21%) | 9 (29%) | 4 (13%) | .12 |
| Steroids current | 33 (53%) | 12 (39%) | 21 (68%) | .02* |
| Steroids ever | 34 (55%) | 12 (39%) | 22 (71%) | .01* |
| History of immuno-modulator therapy | 31 (50%) | 13 (42%) | 18 (58%) | .21 |
| TLC (%) | 82±18 | 83±18 | 82±18 | .92 |
| FVC (%) | 74±20 | 75±21 | 73±20 | .75 |
| FEV1 (%) | 78±24 | 79±25 | 76±24 | .58 |
| DLCO (%) | 76±27 | 78±26 | 73±27 | .42 |
| Left bundle branch block | 0 | 0 | 0 | NS |
| Right bundle branch block | 2 (3%) | 0 | 2 (6%) | .16 |
| 1st/2nd/3rd degree AV block | 5 (8%)/0/0 | 2 (6%)/0/0 | 3 (10%)/0/0 | .67 |
| Holter monitor (N=10) SVT/NSVT | 3/2 | 2/1 | 1/1 | NS |
TLC, total lung capacity; FVC, forced vital capacity; FEV1, forced expiratory volume; DLCO, diffusing capacity for carbon monoxide; LBBB, left bundle branch block; RBBB, right bundle branch block; AV, atrioventricular; SVT, supraventricular tachycardia; NSVT, nonsustained ventricular tachycardia.
*
Statistically significant, P<0.05.